Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Barr's Generic Xanax XR Gains Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Barr’s Generic Xanax XR Gains Approval

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc., received final approval from the FDA for its application to manufacture and market a generic version of Pfizer’s Xanax XR (Alprazolam Extended-Release) Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The company intends to launch this product immediately.

The company’s Alprazolam Extended-Release tablets will compete in a market that had total annual sales of approximately $83 million for the twelve months ending May 2006, according to IMS sales data.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters